Mounjaro 5ml side effects: a clear picture from first dose to settling in

Step 1: what tirzepatide is doing when you use the 5ml pen

The 5ml Mounjaro pen contains 5mg of tirzepatide and delivers one pre-set dose per week. Tirzepatide activates two receptors, GIP and GLP-1, both involved in regulating appetite and blood-sugar levels. One result of that activation is slower gastric emptying: food leaves the stomach more gradually than usual. That is exactly what helps reduce appetite and calorie intake, but it is also the root cause of most side effects if Mounjaro is new to your system at this dose. The stomach is, in effect, learning a new rhythm.

There is a common assumption that moving to the 5mg pen from the 2.5mg starter means side effects will be dramatically worse. For many people, the step up produces only a modest increase in symptoms, and some notice very little change at all. Everyone's response is different, and the full Mounjaro overview covers why that variation happens.

The NHS medicines guidance on tirzepatide, available at nhs.uk/medicines/tirzepatide, lists the recognised side effects at each stage of treatment and is worth bookmarking alongside your Patient Information Leaflet.

Step 2: the side effects that appear most often at 5mg

Nausea is the most frequently reported side effect on 5mg tirzepatide. It tends to peak in the two or three days following an injection and then fade. Eating smaller portions, choosing bland foods and avoiding very fatty meals can all help the stomach cope. Diarrhoea and constipation can both occur, sometimes alternating, because the change in gut motility affects people differently. Indigestion, bloating and burping are also common. Fatigue, mild headaches and dizziness appear in a smaller proportion of users, usually linked to reduced food intake rather than the medicine itself.

Injection-site reactions, including temporary redness, itching or a small lump under the skin, are possible with any subcutaneous injection. Rotating sites every week largely prevents them from becoming a problem.

If you have found that constipation is reducing your progress, the guide on Mounjaro, constipation and weight-loss stalls addresses that combination specifically. For a broader look at the side-effect profile across all doses, the full side effects page gives the wider picture.

Reported rates from the clinical trial programme involving thousands of adults showed GI side effects as the most common reason for dose adjustments. Your prescriber is the right person to guide any change to your schedule.

Step 3: when to get medical help — the signs that should not wait

Most Mounjaro side effects at 5mg are unpleasant rather than dangerous, and they generally settle. A few signs, however, require prompt medical attention.

Severe abdominal pain that is persistent, and particularly pain that spreads toward the back with or without vomiting, can indicate acute pancreatitis. This is an uncommon but serious condition. In January 2026, the MHRA published a Drug Safety Update on GLP-1 receptor agonists reinforcing this risk and advising patients to seek urgent care for these symptoms; you can read it and report any suspected side effects through the Yellow Card scheme. Do not wait for a scheduled review if this pain develops.

Other symptoms warranting urgent contact with a doctor or NHS 111 include: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat); signs of severe dehydration from persistent vomiting or diarrhoea (extreme thirst, very dark urine, dizziness on standing); and gallbladder-related symptoms such as sudden pain in the upper right abdomen. If you have any doubt, call for advice rather than sitting it out.

Some people are understandably nervous about reporting side effects to a prescriber, worrying they might be taken off treatment. Our prescribers hear these concerns regularly; managing side effects is part of the clinical relationship, not a reason to stop. You can reach our team through the contact page seven days a week.

Step 4: what often goes unreported — and the side effects that tend to ease

One thing worth addressing plainly: fatigue in the first couple of weeks is frequently under-reported because people attribute it to dieting. On tirzepatide, a meaningful drop in appetite arrives quickly and, without consciously eating enough protein, some people find their energy dips. This is not the medicine causing harm; it is a signal to look at food quality rather than just quantity. Protein and fibre matter more, not less, when appetite is reduced.

The good news is that the majority of GI side effects associated with the 5ml Mounjaro pen are front-loaded. Clinical data and prescriber experience both point to symptoms settling for most people within a few weeks at a stable dose. A small number of people find that side effects simply do not improve; in those cases a prescriber may consider a slower titration schedule or, occasionally, whether a different treatment is a better fit. Pages covering what to expect specifically at the 5mg dose and reasons some people experience very few side effects explore those patterns in more detail.

If you are considering starting treatment and want to understand your full options, our consultation page sets out how a clinical assessment works and what a prescriber considers before any medicine is recommended.